The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway

被引:49
作者
Boileau, C
Pelletier, JP
Tardif, G
Fahmi, H
Laufer, S
Lavigne, M
Martel-Pelletier, J
机构
[1] Univ Montreal, Notre Dame Hosp, Ctr Hosp, Osteoarthrit Res Unit, Montreal, PQ H2L 4M1, Canada
[2] Univ Tubingen, Tubingen, Germany
[3] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada
关键词
D O I
10.1136/ard.2004.026906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: MMP-13 is one of the most important metalloproteases (MMP) involved in osteoarthritis. Licofelone, a novel dual inhibitor of cyclo-oxygenases ( COX) and 5-lipoxygenase (5-LOX), can modulate MMP-13 production in human osteoarthritis chondrocytes. Objective: To evaluate the impact of licofelone on MMP-13 expression/production, promoter, and major MAP kinase signalling pathways and transcription factors. Methods: Human osteoarthritis chondrocytes were stimulated by interleukin 1 beta ( IL1 beta) and treated with or without: licofelone (0.3, 1, or 3 mg/ml); NS-398 ( 10 mu M; a specific COX-2 inhibitor); or BayX-1005 ( 10 mM; a specific 5-LOX inhibitor). MMP-13 synthesis was determined by specific enzyme linked immunosorbent assay, and expression by real time polymerase chain reaction. The effect of licofelone on the MMP-13 promoter was studied through transient transfection; dexamethasone ( 1027 M) was used as comparison. The effect on IL1 beta induced MMP-13 signalling pathways was determined using specific ELISA for phosphorylated MAP kinases and transcription factors. Results: Licofelone dose dependently inhibited the IL1 beta stimulated production and expression of MMP-13. NS-398 and BayX-1005 had very little effect. Licofelone also inhibited MMP-13 transcription on each of the promoter constructs used. The licofelone inhibition was comparable to that obtained with dexamethasone. Licofelone had no effect on phosphorylated p44/42 or JNK1/2; however, it decreased phosphorylated c-jun and inhibited phosphorylated p38, CREB, and AP-1 activity. Conclusions: Licofelone inhibited MMP-13 production under proinflammatory conditions on human osteoarthritis chondrocytes, through inhibition of the p38/AP-1 pathway and the transcription factor CREB. This may explain some of the mechanisms whereby licofelone exerts its positive effect on osteoarthritic changes.
引用
收藏
页码:891 / 898
页数:8
相关论文
共 55 条
  • [11] TRANSCRIPTION FACTOR INTERACTIONS - SELECTORS OF POSITIVE OR NEGATIVE REGULATION FROM A SINGLE DNA ELEMENT
    DIAMOND, MI
    MINER, JN
    YOSHINAGA, SK
    YAMAMOTO, KR
    [J]. SCIENCE, 1990, 249 (4974) : 1266 - 1272
  • [12] Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1
    Fahmi, H
    Pelletier, JP
    Di Battista, JA
    Cheung, HS
    Fernandes, JC
    Martel-Pelletier, J
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2002, 10 (02) : 100 - 108
  • [13] Fernandes JC, 1998, J RHEUMATOL, V25, P1585
  • [14] Gay RE, 2001, J RHEUMATOL, V28, P2060
  • [15] He W, 2002, J RHEUMATOL, V29, P546
  • [16] ENHANCED GASTRIC-MUCOSAL LEUKOTRIENE-B(4) SYNTHESIS IN PATIENTS TAKING NONSTEROIDAL ANTIINFLAMMATORY DRUGS
    HUDSON, N
    BALSITIS, M
    EVERITT, S
    HAWKEY, CJ
    [J]. GUT, 1993, 34 (06) : 742 - 747
  • [17] Johansson N, 2000, J CELL SCI, V113, P227
  • [18] Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO
  • [19] 2-E
  • [20] Jovanovic DV, 2001, ARTHRITIS RHEUM-US, V44, P2320, DOI 10.1002/1529-0131(200110)44:10<2320::AID-ART394>3.0.CO